Aneurysm-related mortality rates in the US AneuRx clinical trial.
Tavris
Dale R
DR
Food and Drug Administration, Silver Spring, MD, USA.
Liu
Chih-hsin
CH
Gross
Thomas P
TP
Greenfield
Lazar J
LJ
D020341:Absorbable Implants; D017544:Aortic Aneurysm, Abdominal / Q000401:mortality* / Q000628:therapy*; D001019:Aortic Rupture / Q000401:mortality; D001807:Blood Vessel Prosthesis / Q000009:adverse effects / Q000706:statistics & numerical data; D019917:Blood Vessel Prosthesis Implantation / Q000401:mortality*; D015984:Causality; D015331:Cohort Studies; D020878:Device Removal / Q000009:adverse effects / Q000401:mortality; D057867:Endoleak / Q000453:epidemiology / Q000601:surgery; D005500:Follow-Up Studies; D006801:Humans; D011788:Quality of Life; D018570:Risk Assessment; D015607:Stents; D013530:Surgical Wound Infection / Q000453:epidemiology; D015996:Survival Rate; D014481:United States / Q000453:epidemiology